Adenoviral-mediated, high-level, cell-specific transgene expression:: A SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity

被引:99
作者
Glover, CPJ
Bienemann, AS
Heywood, DJ
Cosgrave, AS
Uney, JB [1 ]
机构
[1] Univ Bristol, MRC, Ctr Synapt Plast, Bristol BS2 8HW, Avon, England
[2] Univ Bristol, Unit Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
WPRE; adenovirus; SYN1; promoter; neuronal; gene therapy; cell targeting;
D O I
10.1006/mthe.2002.0588
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Viral vectors are excellent tools for studying gene function in the brain, although a limitation has been the ability to effectively target transgene expression to specific neuronal populations. This generally cannot be overcome by the use of neuron-specific promoters, as most are too large to be used with current viral vectors and expression from these promoters is often relatively weak. We therefore developed a composite expression cassette, comprising 495 by of the weak human SYN1 (synapsin-1) promoter and 800 by of the woodchuck hepatitis virus post-transcriptional regulatory element (WPRE). Studies in hippocampal cultures, organotypic cultures, and in vivo showed that the 3' addition of the WPRE to the SYN1 element greatly increased enhanced green fluorescent protein expression levels with no loss of neuronal specificity. In vivo studies also showed that transgene expression was enhanced with no loss of neuronal specificity in dentate-gyrus neurons for at least 6 weeks following transfection. Therefore, unlike most powerful promoter systems, which mediate expression in neurons and glia, this SYN1-WPRE cassette can target powerful long-term transgene expression to central nervous system neurons when delivered at relatively low titers of adenovirus. Its use should therefore facilitate both gene therapy studies and investigations of neuronal gene function.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 45 条
[1]   Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors [J].
Addison, CL ;
Hitt, M ;
Kunsken, D ;
Graham, FL .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :1653-1661
[2]   Overexpression of hsp70i facilitates reactivation of intracellular proteins in neurones and protects them from denaturing stress [J].
Beaucamp, N ;
Harding, TC ;
Geddes, BJ ;
Williams, J ;
Uney, JB .
FEBS LETTERS, 1998, 441 (02) :215-219
[3]   Hybrid female matings are directly related to the availability of Rana lessonae and Rana esculenta males in experimental populations [J].
Bergen, K ;
Semlitsch, RD ;
Reyer, HU .
COPEIA, 1997, (02) :275-283
[4]   Targeting of high-capacity adenoviral vectors [J].
Biermann, V ;
Volpers, C ;
Hussmann, S ;
Stock, A ;
Kewes, H ;
Schiedner, G ;
Herrmann, A ;
Kochanek, S .
HUMAN GENE THERAPY, 2001, 12 (14) :1757-1769
[5]   REST - A MAMMALIAN SILENCER PROTEIN THAT RESTRICTS SODIUM-CHANNEL GENE-EXPRESSION TO NEURONS [J].
CHONG, JHA ;
TAPIARAMIREZ, J ;
KIM, S ;
TOLEDOARAL, JJ ;
ZHENG, YC ;
BOUTROS, MC ;
ALTSHULLER, YM ;
FROHMAN, MA ;
KRANER, SD ;
MANDEL, G .
CELL, 1995, 80 (06) :949-957
[6]   Gene therapy in the CNS [J].
Costantini, LC ;
Bakowska, JC ;
Breakefield, XO ;
Isacson, O .
GENE THERAPY, 2000, 7 (02) :93-109
[7]   Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element [J].
Donello, JE ;
Loeb, JE ;
Hope, TJ .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5085-5092
[8]   Towards gene therapy for the central nervous system [J].
During, MJ ;
Ashenden, LMA .
MOLECULAR MEDICINE TODAY, 1998, 4 (11) :485-493
[9]   Gene therapy for acute diseases [J].
Factor, P .
MOLECULAR THERAPY, 2001, 4 (06) :515-524
[10]   Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin [J].
Geddes, BJ ;
Harding, TC ;
Lightman, SL ;
Uney, JB .
NATURE MEDICINE, 1997, 3 (12) :1402-1404